Trevena, Inc.
7-membered aza-heterocyclic containing .delta.-opioid receptor modulating compounds, methods of using and making the same

Last updated:

Abstract:

The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.

Status:
Grant
Type:

Utility

Filling date:

15 Feb 2018

Issue date:

18 Jan 2022